New products: Medison, SmartPill, U.S. Preventive Medicine
MEDISON introduced the SonoAce X8, the latest in its line of ultrasound systems. The system has new “smart software” protocol-based ultrasound, leap-frogging conventional Windows-based systems, the company said.  It also allows users to modify system controls with simple steps using new software protocols. The X8 is designed as a true multi-modality ultrasound system, and is able to adapt for abdominal, OB/GYN, small parts, vascular and/or cardiac imaging. SonoAce X8 features a wide variety of premium functions including high-resolution 3D imaging, live 3D, 3DXI, full spectrum imaging, dynamic MR as well as spatial compound imaging. In terms of design, the SonoAce X8 incorporates a high-resolution 17-inch LCD monitor with an articulated arm for optimal ergonomic viewing during the ultrasound examination. The system design and interactive console are equipped for multiple environments with four independent swivel wheels for mobility. The product release date for sale will be in the first half of 2007.

Buffalo, N.Y.’s SmartPill Corp., a developer of capsule-based medical devices, officially launched its SmartPill GI Monitoring System. The system, as well as the SmartPill pH.p Capsule, is now available to gastrointestinal professionals and their patients in the United States. SmartPill received 510(k) release from the federal Food and Drug Administration in July 2006 for the sale and use of the system in the United States. The SmartPill pH.p Capsule and SmartPill GI Monitoring System aid in the evaluation of patients suffering from GI motility disorders, including those suffering from symptoms of slow gastric emptying, a condition known as gastroparesis, which many agree has been underdiagnosed for years. The SmartPill pH.p Capsule is a wireless, ingestible medical device — about the size of a large vitamin pill — that measures pressure and pH, gastric emptying time, combined small and large bowel transit time, and total transit time. The capsule travels through the gastrointestinal tract, collecting and transmitting data to the SmartPill data receiver. The receiver, slightly larger than a cell phone, is worn on a patient’s belt or around the neck on a lanyard. A patient ingests the single-use SmartPill pH.p Capsule in the doctor’s office and within a day or two the patient returns to the doctor, who downloads the information from the SmartPill data receiver.

U.S. Preventive Medicine is creating preventive programs and services designed to detect health risks early and then preventing them from becoming life-threatening diseases or mitigating their severity. These programs include preventive diagnostics such as imaging studies, health risk assessments, counseling and intervention. U.S. Preventive Medicine will work in partnership with leading health systems and physician groups around the country to form The U.S. Prevention Network, a national healthcare network focused exclusively on prevention. The network encompasses Centers for Preventive Medicine, where consumers can access a comprehensive suite of clinically appropriate diagnostic tests and sophisticated imaging studies. The network also will include The Prevention Plan, a full-service prevention program offered through employers.

"It's been estimated that only four percent of America's $2.2 trillion in annual healthcare spending is devoted to prevention. That's why this country continues to experience alarming levels of obesity and serious illnesses like heart disease, stroke, diabetes and cancer," said Christopher T. Fey, chairman and CEO. "Prevention is the solution to this problem. Our nation must embrace a new paradigm of healthcare — one that focuses far more attention and resources on preventing, rather than just treating, major illnesses."

Launching The Prevention Network is the first phase of U.S. Preventive Medicine's national rollout.  Future plans call for online prevention technologies that will broadly increase consumer access to preventive resources. To learn more visit and download "Preventive Medicine: A 'Cure' for the Healthcare Crisis."